CIPSX vs. NCLEX

Last updated Jun 4, 2026

CIPSX (Champlain Small Company Fund) and NCLEX (Nicholas Limited Edition Fund) are both Small Cap Growth Equities funds. Over the past 10 years, CIPSX returned 7.18%/yr vs 7.27%/yr for NCLEX. Their correlation of 0.94 suggests significant overlap in exposure. CIPSX charges 1.26%/yr vs 0.85%/yr for NCLEX.

Performance

CIPSX vs. NCLEX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Champlain Small Company Fund (CIPSX) and Nicholas Limited Edition Fund (NCLEX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CIPSX achieves a 3.44% return, which is significantly higher than NCLEX's -6.20% return. Both investments have delivered pretty close results over the past 10 years, with CIPSX having a 7.18% annualized return and NCLEX not far ahead at 7.27%.

CIPSX

• 1D: 0.69%
• 1M: 5.25%
• YTD: 3.44%
• 6M: -16.12%
• 1Y: -19.45%
• 3Y*: 1.70%
• 5Y*: -1.43%
• 10Y*: 7.18%

NCLEX

• 1D: -0.63%
• 1M: 1.63%
• YTD: -6.20%
• 6M: -7.32%
• 1Y: -11.96%
• 3Y*: 0.87%
• 5Y*: -0.95%
• 10Y*: 7.27%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CIPSX vs. NCLEX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CIPSX Champlain Small Company Fund	3.44%	-22.88%	23.09%	14.01%	-20.83%	12.37%	24.14%	25.02%	-3.35%	10.56%
NCLEX Nicholas Limited Edition Fund	-6.20%	-10.41%	11.91%	17.17%	-23.71%	19.07%	22.67%	27.36%	-0.94%	19.93%

Correlation

The correlation between CIPSX and NCLEX is 0.89, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.89
Correlation (3Y) Calculated over the trailing 3-year period	0.90
Correlation (5Y) Calculated over the trailing 5-year period	0.93
Correlation (10Y) Calculated over the trailing 10-year period	0.92
Correlation (All Time) Calculated using the full available price history since Dec 2, 2004	0.94

The correlation between CIPSX and NCLEX has been stable across timeframes, ranging from 0.89 to 0.94 - a consistent structural relationship.

Return for Risk

CIPSX vs. NCLEX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CIPSX

CIPSX Risk / Return Rank: 1
CIPSX Sharpe Ratio Rank: 1
CIPSX Sortino Ratio Rank: 1
CIPSX Omega Ratio Rank: 1
CIPSX Calmar Ratio Rank: 1
CIPSX Martin Ratio Rank: 1

NCLEX

NCLEX Risk / Return Rank: 1
NCLEX Sharpe Ratio Rank: 1
NCLEX Sortino Ratio Rank: 1
NCLEX Omega Ratio Rank: 1
NCLEX Calmar Ratio Rank: 1
NCLEX Martin Ratio Rank: 1

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CIPSX vs. NCLEX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Champlain Small Company Fund (CIPSX) and Nicholas Limited Edition Fund (NCLEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CIPSX	NCLEX	Difference
Sharpe ratio Return per unit of total volatility	-0.71	-0.64	-0.07
Sortino ratio Return per unit of downside risk	-0.74	-0.81	+0.07
Omega ratio Gain probability vs. loss probability	0.87	0.91	-0.04
Calmar ratio Return relative to maximum drawdown	-0.58	-0.51	-0.08
Martin ratio Return relative to average drawdown	-1.10	-1.06	-0.04
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CIPSX vs. NCLEX - Sharpe Ratio Comparison

The current CIPSX Sharpe Ratio is -0.71, which is comparable to the NCLEX Sharpe Ratio of -0.64. The chart below compares the historical Sharpe Ratios of CIPSX and NCLEX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CIPSX	NCLEX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.71	-0.64	-0.07
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.06	-0.05	-0.01
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.33	0.38	-0.05
Sharpe Ratio (All Time) Calculated using the full available price history	0.39	0.51	-0.12

Drawdowns

CIPSX vs. NCLEX - Drawdown Comparison

The maximum CIPSX drawdown since its inception was -46.42%, roughly equal to the maximum NCLEX drawdown of -48.68%. Use the drawdown chart below to compare losses from any high point for CIPSX and NCLEX.

Drawdown Indicators

	CIPSX	NCLEX	Difference
Max Drawdown Largest peak-to-trough decline	-46.42%	-48.68%	+2.26%
Max Drawdown (1Y) Largest decline over 1 year	-31.56%	-21.36%	-10.20%
Max Drawdown (3Y) Largest decline over 3 years	-33.27%	-28.50%	-4.77%
Max Drawdown (5Y) Largest decline over 5 years	-34.62%	-28.50%	-6.12%
Max Drawdown (10Y) Largest decline over 10 years	-36.09%	-35.79%	-0.30%
Current Drawdown Current decline from peak	-23.28%	-21.53%	-1.75%
Average Drawdown Average peak-to-trough decline	-8.45%	-8.28%	-0.17%
Ulcer Index Depth and duration of drawdowns from previous peaks	16.65%	10.19%	+6.46%

Volatility

CIPSX vs. NCLEX - Volatility Comparison

The current volatility for Champlain Small Company Fund (CIPSX) is 4.02%, while Nicholas Limited Edition Fund (NCLEX) has a volatility of 5.11%. This indicates that CIPSX experiences smaller price fluctuations and is considered to be less risky than NCLEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CIPSX	NCLEX	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.02%	5.11%	-1.09%
Volatility (6M) Calculated over the trailing 6-month period	24.17%	12.12%	+12.05%
Volatility (1Y) Calculated over the trailing 1-year period	25.98%	16.90%	+9.08%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	22.53%	19.52%	+3.01%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	21.82%	19.21%	+2.61%

CIPSX vs. NCLEX - Expense Ratio Comparison

CIPSX has a 1.26% expense ratio, which is higher than NCLEX's 0.85% expense ratio.

Dividends

CIPSX vs. NCLEX - Dividend Comparison

CIPSX has not paid dividends to shareholders, while NCLEX's dividend yield for the trailing twelve months is around 8.03%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CIPSX Champlain Small Company Fund	0.00%	0.00%	16.74%	6.39%	0.36%	4.45%	6.11%	7.96%	13.29%	9.78%	2.72%	2.67%
NCLEX Nicholas Limited Edition Fund	8.03%	7.53%	2.51%	2.43%	6.22%	16.44%	5.10%	5.66%	10.72%	7.97%	10.68%	8.05%

Frequently Asked Questions

Can I hold both CIPSX and NCLEX in my portfolio?

CIPSX and NCLEX have a correlation of 0.89, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CIPSX or NCLEX?

NCLEX has higher volatility (5.11%) compared to CIPSX (4.02%). In terms of maximum drawdown, CIPSX dropped -46.42% vs NCLEX's -48.68%.

Which has better risk-adjusted returns?

NCLEX currently has the higher Sharpe Ratio (-0.64 vs -0.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.